Epithalon: Telomerase Signaling, DNA Binding and Peptide Chemistry

Epithalon is a linear tetrapeptide built from L-alanine, L-glutamic acid, L-aspartic acid and glycine, joined through standard alpha-peptide bonds. Its composition was derived from Epithalamin, a bovine pineal gland extract, and the peptide was covered by Russian Patent 2161501 in 2001. A 2025 review notes the tetrapeptide was later detected within natural pineal polypeptide complexes.

Naming is a practical hazard with this molecule. Epithalamin is the crude bovine extract; Epithalon is the four-residue synthetic peptide drawn from it. The two are chemically distinct, yet chemical databases have merged their synonym lists, so a single PubChem record for CID 219042 carries both the tetrapeptide names and the extract names alongside a second registry number, 64082-79-7. Literature searches on one name will return work on the other.

Structurally the peptide is small, highly polar and heavily anionic. Three of its four residues carry a free carboxyl group, against a single free alpha-amino group at the alanine terminus. Molecular dynamics simulation with the AMBER force field describes two intramolecular salt bridges, formed between the alanine nitrogen and the carboxyl groups of the glutamate and aspartate residues, plus one intramolecular hydrogen bond. Together these contacts substantially reduce the conformational freedom of a peptide that would otherwise be expected to be disordered in solution.

One structural caveat is recorded in the 2025 International Journal of Molecular Sciences review. The peptide contains three asymmetric centres, which permits eight stereoisomers, and only the all-L configuration has been characterized in published work. The same review reports that a single earlier publication proposed an alternative double-gamma-bonded connectivity that no other group has reproduced.

Epithalon has been examined for telomerase effects since 2003, when a Russian group reported that adding the peptide to telomerase-negative human fetal fibroblast cultures induced catalytic subunit expression, telomerase activity and telomere elongation. An independent group at Brunel University London revisited the question in human cell lines in Biogerontology in 2025.

That 2025 study used four cell types plus two reference lines: the breast cancer lines 21NT and BT474, the fibroblast line IBR.3, primary human mammary epithelial cells, with U2OS as an ALT-positive control and PC3-hTERT as a telomerase-positive control. Cancer lines were exposed to 0.1, 0.2, 0.5 and 1.0 micrograms per millilitre for four days; the normal lines were exposed to 1.0 micrograms per millilitre for three weeks.

The measured outcomes split by cell type, and that split is the interesting part. In the normal lines, TRAP telomerase activity rose roughly 26-fold in mammary epithelial cells and about fourfold in IBR.3 fibroblasts. In the two cancer lines, TRAP activity did not rise significantly; instead the C-circle assay showed roughly a tenfold rise in 21NT and a threefold rise in BT474, with PML body staining consistent with alternative lengthening of telomeres. Telomere length rose in both groups, from about 2.4 kb to about 4 kb in 21NT and to a maximum near 8 kb in BT474. hTERT mRNA rose about 12-fold in 21NT at 1 microgram per millilitre and about fivefold in BT474 at 0.5 micrograms per millilitre. Comparisons were made by one-way ANOVA at p less than 0.05.

Two qualifications belong on the record. First, the authors of that paper issued a correction in Biogerontology in November 2025 covering errors in the published figures; the correction notice is listed in the references below. Second, the finding that telomere extension in malignant lines ran through ALT rather than telomerase activation is a mechanistically distinct route from the one described in normal cells, and the paper reports them as separate observations rather than a single effect.

A second 2025 report worked in a reproductive model. Ullah and colleagues, publishing in Life Sciences, measured TERT protein and telomerase activity in bovine cumulus cells and cumulus-oocyte complexes, and reported that peptide exposure raised telomerase activity, lowered intracellular reactive oxygen species, improved mitochondrial measures, raised the oocyte maturation rate and raised post-thaw blastocyst hatching rate and implantation potential, each at p less than 0.05.

Epithalon is proposed to act on gene expression through direct nucleic acid and chromatin contact rather than a cell-surface receptor. The 2025 review describes binding to the DNA sequences ATTTG and ATTTC through hydrophobic contacts with thymine methyl groups plus hydrogen bonds, and a drop in double-stranded DNA melting temperature of up to 41 degrees Celsius.

That melting-point figure was recorded at 0.1 M NaCl, and a related mechanism concerns methylation. Ultrashort peptides of this family bind single- and double-stranded deoxyribonucleotides and associate with CNG and CG promoter sites, the targets of DNA cytosine methyltransferases in eukaryotes. Occupancy at those sites is proposed to render them less accessible to the methyltransferases, which would place the peptide upstream of transcription rather than at the promoter output.

The chromatin side of the picture comes from a 2020 study in Molecules. Khavinson and colleagues docked the AEDG peptide against six histone proteins and found suitable sites only on the linker histones, scoring minus 64.51 kcal/mol at histone H1/6, at the site Tyr-Arg-Lys-Thr-Gln, and minus 56.49 kcal/mol at H1/3. Core histones H2b, H3 and H4 returned no suitable site. In the same paper, human gingival mesenchymal stem cells exposed to 0.01 micrograms per millilitre for one week showed Nestin, GAP43, beta-tubulin III and doublecortin mRNA raised 1.6 to 1.8-fold against control at p less than 0.01.

Cytogenetic work points in a compatible direction. Lezhava and colleagues reported in Georgian Medical News in 2023 that Epitalon, Livagen and Vilon produced chromatin decondensation, described as deheterochromatinization, in cultured lymphocytes from elderly donors, replicating an observation the same group had published earlier. Taken together, the DNA-melting, methylation-site and linker-histone strands all describe an accessibility mechanism, though none of them has been resolved structurally.

Epithalon is characterized in the literature as an antioxidant peptide, and the clearest recent data come from a 2025 study in Stem Cell Reviews and Reports using ARPE-19 human retinal pigment epithelial cells. Cells were held at 35 mM glucose for 72 hours, with the peptide supplied at 20, 40 and 60 nanograms per millilitre.

Menadione at 20 micromolar served as the oxidative-stress positive control in that design. High glucose slowed scratch closure, raised intracellular reactive oxygen species and lowered antioxidant gene expression. At 40 and 60 nanograms per millilitre the peptide lowered glucose-driven hydrogen peroxide generation and attenuated the fall in SOD2, CAT and HMOX1 expression. The same exposure attenuated the glucose-induced epithelial-mesenchymal transition and the upregulation of fibrosis-associated genes. The authors state that further mechanistic work is required.

An earlier report in Aging examined mouse oocytes aged in vitro after ovulation, with the peptide at 0.1 mM in the culture medium and quality scored at 6, 12 and 24 hours. Intracellular reactive oxygen species fell, spindle defects and abnormal cortical granule distribution were less frequent at 12 and 24 hours, mitochondrial membrane potential and mitochondrial DNA copy number rose, and apoptosis at 24 hours of in vitro aging fell.

The 2025 review adds an invertebrate anchor and a concentration curiosity. Drosophila melanogaster given 0.00001 percent by weight at the early larval stage showed a 16 percent extension of adult lifespan, while murine thymocytes showed maximal proliferation between 10 to the minus 17 and 10 to the minus 15 molar, a range far below conventional pharmacological concentrations. The same review reports acetylcholinesterase and butyrylcholinesterase activity raised 10 to 25 percent in SH-SY5Y neuroblastoma cells, with soluble amyloid precursor protein secretion raised about 20 percent.

Epithalon appears in several models of neuronal and cellular aging, and 2024 work in the International Journal of Molecular Sciences is the most methodologically careful. Kraskovskaya and colleagues transdifferentiated dermal fibroblasts from three elderly donors, aged 61, 66 and 68, into induced cortical neurons, then applied AEDG, EDR and KED peptides at 10 micrograms per millilitre.

Exposure ran for 10 days during differentiation, with analysis on day 11. For the AEDG peptide, the number of primary processes rose 34 percent, from 4.59 plus or minus 0.3 to 6.18 plus or minus 0.4 at p equal to 0.0046, and total dendrite length rose 32 percent, from 270.2 plus or minus 25.5 to 357.8 plus or minus 30 at p equal to 0.05. The negative results in that paper are equally informative: changes in p16, LaminB1, 8-OHdG oxidative DNA damage, mitochondrial activity and lysosomal activity did not reach statistical significance for this peptide. Reduction in oxidative DNA damage was specific to the EDR tripeptide.

A 2024 review in Advances in Gerontology surveyed buccal epithelium as a marker tissue and reported associations between pineal polypeptides, the AEDG peptide and expression of circadian genes Cry2, AANAT, ASMT and CLOCK, alongside changes in p16, p21 and p53 and modulation of TERF-1, prohibitin, SIRT1 and SIRT6.

The most recent framing comes from a narrative review published in Frontiers in Aging in 2026. Mavrych and colleagues searched PubMed, Scopus and regulatory registers through January 2026 and grouped nine peptides by the aging hallmark each addresses, placing this one under telomere biology. Their assessment of the evidence base is direct: unapproved compounds in the set rest on preclinical and limited clinical data, lack systematic confirmation, and carry gaps in toxicology data and in validated biomarkers for effect assessment. That is the fairest summary of where the compound sits in 2026.

Epithalon is supplied as a lyophilized solid, and the first handling question is salt form rather than storage. Commercial material exists as the acetate or trifluoroacetate salt, and those are separate chemical entities from the free peptide: the free peptide is C14H22N4O9 at 390.35 g/mol under CAS 307297-39-8, while catalogues list the acetate as C16H26N4O11 at 450.4 g/mol under CAS 307297-40-1. Gravimetric calculations that assume the free-peptide mass will be roughly 13 percent off when the material is an acetate. Certificates of analysis that report peptide content separately from HPLC purity resolve this; those that report only purity do not.

Identity confirmation has a documented pitfall specific to this sequence. The 2025 review describes an isomeric impurity, EADG (Glu-Ala-Asp-Gly), which differs only in the order of the first two residues and therefore shares the exact mass of the target peptide. Liquid chromatography with tandem mass spectrometry distinguishes the two by exploiting heat-induced cyclization of an N-terminal glutamic acid to pyroglutamate, which lowers the observed mass in the isomer but not in Ala-Glu-Asp-Gly. The review reports this method being applied to commercial preparations between 2012 and 2017, so the isomer is a real-world contaminant rather than a theoretical one.

Chemically the molecule is polar and anionic, carrying three free carboxyl groups against one free amino group, which is consistent with aqueous solubility and with the hygroscopic behaviour typical of lyophilized acidic peptides. Suppliers specify storage of the solid at minus 20 degrees Celsius. These are catalogue specifications rather than published stability measurements; no peer-reviewed degradation kinetics, pH-dependent solubility curve or isoelectric point determination for this peptide was located, and the 2025 review states directly that physicochemical and structural investigation of the molecule remains limited.

Two further gaps are worth recording before designing work with the material. Stereochemical purity is rarely specified even though eight stereoisomers are possible and only the all-L form has been studied. And the same review states that information on short- and long-term toxicity, including genotoxicity and carcinogenic potential, is missing from the literature. Research use only; not for human or veterinary use.